Literature DB >> 24958718

Pulmonary endarterectomy: part I. Pathophysiology, clinical manifestations, and diagnostic evaluation of chronic thromboembolic pulmonary hypertension.

Dalia A Banks1, Gert Victor D Pretorius2, Kim M Kerr2, Gerard R Manecke2.   

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) results from recurrent or incomplete resolution of pulmonary embolism. CTEPH is much more common than generally appreciated. Although pulmonary embolism (PE) affects a large number of Americans, chronic pulmonary hypertension (PH) remains underdiagnosed. It is imperative that all patients with PH be screened for the presence of CTEPH since this form of PH is potentially curable with pulmonary thromboendarterectomy (PTE) surgery. The success of this procedure depends greatly on the collaboration of a multidisciplinary team approach that includes pulmonary medicine, cardiothoracic surgery, and cardiac anesthesiology. This review, based on the experience of more than 3000 pulmonary endarterectomy surgeries, is divided into 2 parts. Part I focuses on the clinical history and pathophysiology, diagnostic workup, and intraoperative echocardiography. Part II focuses on the surgical approach, anesthetic management, postoperative care, and complications.
© The Author(s) 2014.

Entities:  

Keywords:  chronic thromboembolic pulmonary hypertension; diagnostic evaluation of CTEPH; pulmonary artery pressure; pulmonary thromboendarterectomy; right heart failure; transesophageal echocardiography in PTE

Mesh:

Year:  2014        PMID: 24958718     DOI: 10.1177/1089253214536621

Source DB:  PubMed          Journal:  Semin Cardiothorac Vasc Anesth        ISSN: 1089-2532


  6 in total

Review 1.  Pathophysiology and treatment of pulmonary hypertension in sickle cell disease.

Authors:  Victor R Gordeuk; Oswaldo L Castro; Roberto F Machado
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

Review 2.  Surgical Management of Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Andrew M Vekstein; Joseph R Nellis; Sharon L McCartney; John C Haney
Journal:  Cardiol Clin       Date:  2022-02       Impact factor: 2.213

Review 3.  Chronic thromboembolic pulmonary hypertension: the magic of pathophysiology.

Authors:  Gérald Simonneau; Peter Dorfmüller; Christophe Guignabert; Olaf Mercier; Marc Humbert
Journal:  Ann Cardiothorac Surg       Date:  2022-03

4.  Changed hemodynamics in acute vasoreactivity testing: prognostic predictors in chronic thromboembolic pulmonary hypertension.

Authors:  Yan-Zhe Yu; Ping Yuan; Yi-Lan Yang; Yuan-Yuan Sun; Qin-Hua Zhao; Lan Wang; Rong Jiang; Wen-Hui Wu; Jing He; Jing-Hong Dai; Yuan Li; Bigyan Pudasaini; Jin-Ling Li; Su-Gang Gong; Wei-Ping Xie; Jin-Ming Liu
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

5.  Balloon pulmonary angioplasty vs riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.

Authors:  Wuwan Wang; Li Wen; Zhengdong Song; Wenhai Shi; Ke Wang; Wei Huang
Journal:  Clin Cardiol       Date:  2019-06-12       Impact factor: 2.882

6.  Acute vasoreactivity testing predicts outcome of idiopathic pulmonary arterial hypertension patients with a negative acute response.

Authors:  Yuanyuan Sun; Yuan Li; Xiangrui Meng; Rong Jiang; Qinhua Zhao; Lan Wang; Lingzi Shi; Cijun Luo; Hongling Qiu; Wenhui Wu; Jinling Li; Jing He; Jinming Liu; Ping Yuan; Sugang Gong
Journal:  Ann Transl Med       Date:  2020-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.